More than 8 in 10 employers intend to offer employees and their dependents access to lower- or no-cost mental health support through their tele-mental health provider this year, the letter said.
Medicare Part D spending for 10 selected diabetes drugs surged from $7.7 billion in 2019 to $35.8 billion in 2023, an audit by the U.S. Department of Health and Human Services Office of Inspector General found.
The federal 340B drug pricing program is failing to meet the needs of the vulnerable patients the program was intended to serve, while raising health care costs for employers and families, according to a new white paper.
The Biden administration’s agenda, which sought to provide Medicaid-funded emergency services to undocumented immigrants, has cost federal and state taxpayers more than $16.2 billion, according to Congressional Budget Office estimates.
Proposed legislation could make California one of only a handful of states that require insurers to disclose denial rates and reasoning, which the industry often considers proprietary information.